UNC Lineberger News

DeSimone elected to all three branches of the National Academies

DeSimone elected to all three branches of the National Academies

Dr. Joseph DeSimone, Chancellor’s Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill and UNC Lineberger member, has been elected to the Institute of Medicine, one of the highest honors in the fields of health and medicine a U. S. scientist can receive.

DeSimone elected to all three branches of the National Academies - Read More…

Having dependent children motivates advanced cancer patients to pursue more aggressive care

A pilot study of people with advanced cancer indicates that parental status is an important factor in treatment decision-making, with the majority stating that being a parent motivates them to pursue life-extending treatments, according to research presented this week at ASCO’s 2014 Quality Care Symposium by Devon Check, a Ph.D. student at the University of North Carolina at Chapel Hill.

Having dependent children motivates advanced cancer patients to pursue more aggressive care - Read More…

New Template for Survivorship Care Plans Released

New Template for Survivorship Care Plans Released

Deborah K. Mayer, PhD, RN, professor in the UNC School of Nursing and director of cancer survivorship at UNC Lineberger, leads national efforts to address growing need for post-treatment planning for cancer patients.

New Template for Survivorship Care Plans Released - Read More…

Endeavors: Just Add Liver

Endeavors: Just Add Liver

A tale of viruses, stem cells, and global health

Endeavors: Just Add Liver - Read More…

Inaugural She ROCKS luncheon raises funds for ovarian cancer

Inaugural She ROCKS luncheon raises funds for ovarian cancer

The first annual She ROCKS (Research, Ovarian, Cancer, Knowledge, Support) event held recently in Wilmington raised funds that will go directly towards ovarian cancer research based at UNC Lineberger Comprehensive Cancer Center.

Inaugural She ROCKS luncheon raises funds for ovarian cancer - Read More…

All the Cell’s a Stage

All the Cell’s a Stage

Brian Strahl, PhD, and his band of biochemists unravel the complicated mysteries of the epigenetic code to find a culprit in cancer development.

All the Cell’s a Stage - Read More…

New website launched to help women learn about risk factors for breast cancer

New website launched to help women learn about risk factors for breast cancer

The UNC Breast Cancer and the Environment Research Program (BCERP) has announced the official launch of myBCrisk.org, an interactive website designed to increase knowledge about breast cancer risk factors, especially among young African-American women.

New website launched to help women learn about risk factors for breast cancer - Read More…

Coach Hatchell inspires as featured speaker at 10th Annual Roy Williams' Fast Break Against Cancer

Coach Hatchell inspires as featured speaker at 10th Annual Roy Williams' Fast Break Against Cancer

Now in its 10th year, this annual event hosted by Coach Roy Williams raised $213,000 for cancer research and treatment at UNC Lineberger Comprehensive Cancer Center.

Coach Hatchell inspires as featured speaker at 10th Annual Roy Williams' Fast Break Against Cancer - Read More…

Milowsky appointed medical director of the N.C. Cancer Hospital

Milowsky appointed medical director of the N.C. Cancer Hospital

CHAPEL HILL, NC – Matthew Milowsky, MD, associate professor and co-director of the Urologic Oncology Program at UNC Lineberger Comprehensive Cancer Center, has been appointed as the clinic medical director of the N.C. Cancer Hospital.

Milowsky appointed medical director of the N.C. Cancer Hospital - Read More…

Komen awards more than $875,000 to UNC Lineberger researchers

Komen awards more than $875,000 to UNC Lineberger researchers

Susan G. Komen® has awarded over $875,000 in research funding to UNC Lineberger Comprehensive Cancer Center.

Komen awards more than $875,000 to UNC Lineberger researchers - Read More…

Team UNC Oncology among top fundraising teams for Light The Night Walk

Team UNC Oncology among top fundraising teams for Light The Night Walk

The Leukemia & Lymphoma Society (LLS) held their Light The Night Walk at Rock Quarry Park in Durham on Saturday, September 20. The evening fundraising walk celebrated and commemorated lives touched by blood cancer. More than a walk, the evening had a carnival atmosphere and included refreshments, entertainment, music and kids' activities

Team UNC Oncology among top fundraising teams for Light The Night Walk - Read More…

UNC Lineberger hosts Metastatic Breast Cancer Network Conference

UNC Lineberger hosts Metastatic Breast Cancer Network Conference

The Metastatic Breast Cancer Network (MBCN) held its 8th Annual National Conference in Chapel Hill September 19-21, 2014 in conjunction with the UNC Lineberger Comprehensive Cancer Center.

UNC Lineberger hosts Metastatic Breast Cancer Network Conference - Read More…

Nielsen named Director of UNC Urologic Oncology

Nielsen named Director of UNC Urologic Oncology

Matthew Nielsen, MD, MS, assistant professor of urology and adjunct assistant professor of epidemiology and health policy & management, has been named director of urologic oncology in the UNC Department of Urology. In his new role, he joins Matthew Milowsky, MD, associate professor of medicine, as co-director of the Multidisciplinary Genitourinary Oncology Service at the N.C. Cancer Hospital.

Nielsen named Director of UNC Urologic Oncology - Read More…

Sharon Campbell honored at the 2014 Hyman L. Battle Distinguished Cancer Research Award reception

Sharon Campbell honored at the 2014 Hyman L. Battle Distinguished Cancer Research Award reception

On September 24, 2014, UNC Lineberger held a reception to honor Dr. Sharon Campbell, recipient of the 2014 Hyman L. Battle Distinguished Cancer Research Award.

Sharon Campbell honored at the 2014 Hyman L. Battle Distinguished Cancer Research Award reception - Read More…

The Geneticist

The Geneticist

With his selection to the NIH Council of Councils, Terry Magnuson, PhD, becomes the first UNC scientist appointed to the board dedicated to funding the biggest ideas in medical research.

The Geneticist - Read More…

UNC researchers find final pieces to the circadian clock puzzle

UNC researchers find final pieces to the circadian clock puzzle

Sixteen years after scientists found the genes that control the circadian clock in all cells, the lab of UNC’s Aziz Sancar, MD, PhD, discovered the mechanisms responsible for keeping the clock in sync.

UNC researchers find final pieces to the circadian clock puzzle - Read More…

Damania appointed Assistant Dean for Research

Damania appointed Assistant Dean for Research

Blossom Damania, PhD, professor of microbiology and immunology, has been named Assistant Dean for Research at the UNC School of Medicine, effective immediately.

Damania appointed Assistant Dean for Research - Read More…

Basch contributes to new ASCO guidelines for prostate cancer treatment

Basch contributes to new ASCO guidelines for prostate cancer treatment

New clinical guidelines have been announced for the treatment of men with metastatic castration-resistant prostate cancer (CRPC) by the American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO). Ethan Basch, MD, director of the Cancer Outcomes Research Program at UNC Lineberger Comprehensive Cancer Center, served as the co-chair of the ASCO/CCO expert panel that developed the guideline.

Basch contributes to new ASCO guidelines for prostate cancer treatment - Read More…

UNC researchers find new genetic target for a different kind of cancer drug

UNC researchers find new genetic target for a different kind of cancer drug

Upstream of the proteins that cancer cells use to proliferate sits RBM4, a gene-splicing protein that UNC researcher Zefeng Wang, PhD, discovered is drastically reduced in human lung and breast cancer cells.

UNC researchers find new genetic target for a different kind of cancer drug - Read More…

Popular cancer drug target implicated in cardiovascular defects

Popular cancer drug target implicated in cardiovascular defects

Research led by UNC’s Kathleen Caron, PhD, shows that halting the protein CXCR7 leads to over activation of adrenomedullin, a hormone needed at proper levels for normal cardiovascular development

Popular cancer drug target implicated in cardiovascular defects - Read More…

Changing the face of clinical trials

Changing the face of clinical trials

UNC Lineberger secures three major NCI grants to advance the nation’s clinical trials program.

Changing the face of clinical trials - Read More…

Anders presents at 13th Annual Round Asia Oncology Forum

Anders presents at 13th Annual Round Asia Oncology Forum

Carey Anders, MD, UNC Lineberger member and associate professor, was a presenter and moderator at The 13th Annual Round Asia Oncology Forum (RAOF) in Hong Kong on August 29 - 30, 2014. The theme of this year’s forum was “Expanding our armory in personalized cancer treatment.”

Anders presents at 13th Annual Round Asia Oncology Forum - Read More…

Eshelman gives $3 million gift to Center for Integrative Chemical Biology and Drug Discovery

Eshelman gives $3 million gift to Center for Integrative Chemical Biology and Drug Discovery

The UNC Eshelman School of Pharmacy has received a $3 million gift from philanthropist and pharmaceutical-industry executive Fred Eshelman. Eshelman’s gift will support the work of the School’s Center for Integrative Chemical Biology and Drug Discovery, led by UNC Lineberger member Stephen Frye, PhD. The center is dedicated to evaluating and developing potential drug targets discovered by UNC faculty.

Eshelman gives $3 million gift to Center for Integrative Chemical Biology and Drug Discovery - Read More…

2014 University Cancer Research Fund Innovation Awards announced

Six researchers have been awarded 2014 University Cancer Research Fund (UCRF) Innovation Awards for promoting innovative and new ideas in cancer research at the University of North Carolina at Chapel Hill.

2014 University Cancer Research Fund Innovation Awards announced - Read More…

Field of Hope honors cancer survivors and raises money for Kay Yow Cancer Fund

Field of Hope honors cancer survivors and raises money for Kay Yow Cancer Fund

UNC Health Care and Rex Healthcare co-sponsored “Field of Hope” at the Durham Bulls game on Saturday, August 23 with a portion of special ticket sales going to the Kay Yow Cancer Fund.

Field of Hope honors cancer survivors and raises money for Kay Yow Cancer Fund - Read More…

Lung Cancer Initiative of NC Hosts 4th Lung Cancer Advocacy Summit

Lung Cancer Initiative of NC Hosts 4th Lung Cancer Advocacy Summit

The Lung Cancer Initiative of NC hosted a statewide Lung Cancer Summit on August 23 at the N.C. Cancer Hospital. Lung cancer advocates were bolstered with training, resources, knowledge and the courage to take action. UNC Lineberger Comprehensive Cancer Center was the Host Sponsor of the event.

Lung Cancer Initiative of NC Hosts 4th Lung Cancer Advocacy Summit - Read More…

The Ras Tracker

The Ras Tracker

For more than 20 years, Sharon Campbell, PhD, has been studying Ras, a protein implicated in 30 percent of all cancers. Now she’s on the hunt for alternative ways to shut the protein down.

The Ras Tracker - Read More…

UNC researchers trade lab coats for running shoes

UNC researchers trade lab coats for running shoes

Kirsten Bryant, PhD, was recently recognized by the Pancreatic Cancer Action Network for her dual role in the fight against pancreatic cancer.

UNC researchers trade lab coats for running shoes - Read More…

UNC Lineberger researchers develop new approach to identify “drivers” of cancer

UNC Lineberger Comprehensive Cancer Center researchers have developed a new integrated approach to pinpoint the genetic “drivers” of cancer, uncovering eight genes that could be viable for targeted breast cancer therapy. The study, published online August 24 in Nature Genetics, was authored by Michael Gatza, PhD, lead author and post-doctoral research associate; Grace Silva, graduate student; Joel Parker, PhD, director of bioinformatics, UNC Lineberger; Cheng Fan, research associate; and senior author Chuck Perou, PhD, professor of genetics and pathology.

UNC Lineberger researchers develop new approach to identify “drivers” of cancer - Read More…

UNC researchers lead project to sequence rare kidney cancer

UNC researchers lead project to sequence rare kidney cancer

An international scientific collaboration led by researchers at UNC has revealed new insights into the unique genetic alterations that contribute to a rare form of kidney cancer.

UNC researchers lead project to sequence rare kidney cancer - Read More…

Older Patients with Limited Life Expectancy Still Receive Cancer Screenings

Older Patients with Limited Life Expectancy Still Receive Cancer Screenings

A substantial number of older patients with limited life expectancy receive routine screenings for prostate, breast, cervical and colorectal cancer even though the procedures are unlikely to benefit them, according to research conducted at the University of North Carolina at Chapel Hill.

Older Patients with Limited Life Expectancy Still Receive Cancer Screenings - Read More…

UNC Lineberger announces Developmental Research Award winners

UNC Lineberger Comprehensive Cancer Center has awarded nine researchers with Developmental Research Awards to support their work in advancing the fields of clinical/translational and population science cancer research.

UNC Lineberger announces Developmental Research Award winners - Read More…

UNC Cancer Care’s statewide multidisciplinary approach highlighted in Health Leaders Media

UNC Cancer Care’s statewide multidisciplinary approach highlighted in Health Leaders Media

A recent article published in the July/August 2014 issue of Health Leaders magazine focuses on some of UNC Lineberger’s strengths that rank it among the nation’s leading cancer centers.

UNC Cancer Care’s statewide multidisciplinary approach highlighted in Health Leaders Media - Read More…

U.S. News article highlights nation’s top cancer centers, cites UNC Lineberger

A recent U.S. News & World Report article highlights the nation’s cancer centers, focusing especially on those that the National Cancer Institute has designated as comprehensive cancer centers, citing advantages of patients being seen at or referred to these sites, including advances in technology and collaboration.

U.S. News article highlights nation’s top cancer centers, cites UNC Lineberger - Read More…

Largest cancer genetic analysis reveals new way of classifying cancer

Largest cancer genetic analysis reveals new way of classifying cancer

Researchers with The Cancer Genome Atlas (TCGA) Research Network have completed the largest, most diverse tumor genetic analysis ever conducted, revealing a new approach to classifying cancers. The work, led by researchers at the UNC Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill and other TCGA sites, not only revamps traditional ideas of how cancers are diagnosed and treated, but could also have a profound impact on the future landscape of drug development.

Largest cancer genetic analysis reveals new way of classifying cancer - Read More…

Genetic mutations linked to salivary gland tumors may point to new therapies

Genetic mutations linked to salivary gland tumors may point to new therapies

Faculty members at the University of North Carolina School of Dentistry, The Scripps Research Institute (TSRI) and other institutions have discovered links between a set of genes known to promote tumor growth and mucoepidermoid carcinoma, an oral cancer that affects the salivary glands. The discovery could help physicians develop new treatments that target the cancer’s underlying genetic causes.

Genetic mutations linked to salivary gland tumors may point to new therapies - Read More…

Remembering Dr. Feng Liu

Remembering Dr. Feng Liu

Feng Liu, PhD, a research professor in the Division of Molecular Pharmaceutics and UNC Lineberger member, died tragically Thursday, July 24, after being assaulted and robbed while walking in a neighborhood near campus. Liu was a dedicated colleague, educator and researcher focused on gene and drug delivery.

Remembering Dr. Feng Liu - Read More…

UNC researchers discover how Hepatitis C virus persists for years

UNC researchers discover how Hepatitis C virus persists for years

Hepatitis C virus (HCV) lingers in the human body for years, slowly damaging the liver and leading to liver diseases such as hepatitis, cirrhosis and liver cancer, which is often fatal. Research conducted at the University of North Carolina at Chapel Hill has discovered a mechanism that facilitates the virus achieving this life-long persistence. Chronic HCV infection is the leading cause of liver cancer in the United States.

UNC researchers discover how Hepatitis C virus persists for years - Read More…

[1]